A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ajay Gopal, MD
Associate Professor of Medicine, Department of Medicine, University of Washington, Seattle, Washington.
Principal Investigator - Anand Pathak, MD
Medical Oncologist, Cancer Care Clinic and Hospital, Nagpur, India
Principal Investigator - Andre Goy, MD
Director of Lymphoma and Deputy Director of Cancer Center, Hackensack University Medical Center, Hackensack
Principal Investigator - Brad Kahl, MD
Director of the Lymphoma Service and Associate Professor of Medicine, University of Wisconsin- Madison
Principal Investigator - Cecil Ross, MD
Consultant Oncologist, St. Johns Medical College & Hospital, Bangalore, India
Principal Investigator - Craig Reeder, MD
Consultant, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Arizona
Principal Investigator - Gabrail Nashat, MD
CEO, President, Gabrail Cancer Center
Principal Investigator - Kirushna kumar, MD
Consultant Oncologist, Meenakshi mission hospital and research centre, Madurai, India
Principal Investigator - Martha Glenn, MD
Associate Professor of Medicine, Huntsman Cancer Institute, Salt Lake City
Principal Investigator - N K Warrier, MD
Senior Consultant Oncologist, Malabar Institute of Medical Sciences, Calicut, India
Principal Investigator - Nishitha Reddy, MD
Vanderbilt University Medical Center, Nashville
Principal Investigator - Patrick Johnston, MD
Associate Professor of Medicine, College of Medicine, Mayo Clinic, Rochester, USA
Principal Investigator - Reena Nair, MD
Professor and Medical Oncologist, Tata Memorial Hospital, Mumbai, India
Principal Investigator - Roger Lyons, MD
President, Cancer Care Centers of South Texas , San Antonio
Principal Investigator - S H Advani, MD
Consultant Oncologist, Jaslok Hospital and Research Centre, Mumbai, India
Principal Investigator - Vinod Raina, MD
Head Dept of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Johns Medical College & Hospital
Bangalore, Karnataka, India
- Malabar Institute of Medical Sciences
Calicut, Kerala, India
- Jaslok Hospital and Research Centre
Mumbai, Maharashtra, India
- Tata Memorial Hospital
Mumbai, Maharashtra, India
- Cancer Care Clinic and Hospital
Nagpur, Maharashtra, India
- Institute Rotary Cancer Hospital, All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India
- Meenakshi Mission Hospital and Research Centre
Madurai, Tamil Nadu, India
- Division of Hematology/oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona
Phoenix, Arizona, United States
- Division of Hematology/oncology, Department of Internal Medicine, Mayo Clinic, Arizona
Scottsdale, Arizona, United States
- College of Medicine, Mayo Clinic
Rochester, Minnesota, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Gabrail Cancer Center Research
Canton, Ohio, United States
- Gabrail Cancer Center Research
Dover, Ohio, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Cancer Care Centers of South Texas
New Braunfels, Texas, United States
- Cancer Care Centers of South Texas
San Antonio, Texas, United States
- Huntsman Cancer Institute, 2000 Circle of Hope, Room 2145
Salt Lake City, Utah, United States
- Department of Medicine, University of Washington
Seattle, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- Dept of Hematology/oncology, University of Wisconsin- Madison
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2009
- Primary completion
- 28 Feb 2011
- Completion
- 31 Aug 2012
- Last update posted
- 27 Jul 2012
- Registered enrollment
- 13
- Registry id
- NCT00843050
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.